Osiris Therapeutics Offers Update on NASDAQ Listing Matters: Co. Requested Added Time to File Delinquent Reports at Nov. 10, 2016 Hearing; Co. Continues to Work Diligently to Close Previously Announced Accounting Reviews
Paul Quintaro